byrondcrowe Profile Banner
Byron Crowe Profile
Byron Crowe

@byrondcrowe

Followers
227
Following
239
Statuses
425

CMO at Solera Health. Academic hospitalist @BIDMChealth @HarvardMed. I tweet about the digital transformation of medicine.

Boston, MA
Joined August 2012
Don't wanna be here? Send us removal request.
@byrondcrowe
Byron Crowe
1 month
RT @ItaiYanai: It’s crazy how talking with a science buddy is simultaneously what’s most likely to move the project forward and the thing t…
0
490
0
@byrondcrowe
Byron Crowe
3 months
0
0
1
@byrondcrowe
Byron Crowe
3 months
This work was was the culmination of a dedicated group of 21 academic internists representing 16 unique institutions who brought their combined expertise in clinical medicine, healthcare operations, clinical informatics, health policy and ethics/equity to bear. You can read the entire position statement, including all 32 recommendations, at the link below. ✍🏻Recommendations for Clinicians, Technologists, and Healthcare Organizations on the Use of Generative Artificial Intelligence in Medicine: A Position Statement from the Society of General Internal Medicine. JGIM. 2024.
0
0
1
@byrondcrowe
Byron Crowe
3 months
RT @AdamRodmanMD: Computer scientists working on medical tasks -- please talk to people in healthcare. The existing benchmarks are sooooo b…
0
6
0
@byrondcrowe
Byron Crowe
3 months
RT @emollick: I think an issue with the next generation of AI is that most people don’t have good test cases ready for them. Yes, everyone…
0
28
0
@byrondcrowe
Byron Crowe
3 months
@AdamRodmanMD Agreed fully that it’s a multifacted problem and ridding ourselves of EHRs is not realistic. But reducing screen time is attainable!
0
0
0
@byrondcrowe
Byron Crowe
5 months
RT @chrissyfarr: If anyone starts a company that is really focused on marketing health solutions to employees/members in Gen Z and millenni…
0
11
0
@byrondcrowe
Byron Crowe
5 months
A question on my mind that I would enjoy some commentary on: how much of the health benefits that we’re seeing with GLP-1s are simply due to rolling back the negative impacts of our horrendous food environment vs a direct drug effect?
@ScienceMagazine
Science Magazine
7 months
A new #SciencePerspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders. Read more:
Tweet media one
0
0
1
@byrondcrowe
Byron Crowe
5 months
Breaking: “Sad Partners” nominated by Webster’s for best new addition to the English language in 2024
@drmoneymatters
Doctor Money Matters
5 months
This week I had so many Sad Partners reach out to me about the state of their Radiology practices which sold to private equity. Meanwhile, the private equity groups are still having “nights out” to try to recruit residents and new radiologists. Good luck🤣 They know better
0
0
3
@byrondcrowe
Byron Crowe
6 months
RT @emollick: Organizations have not fully thought through AI. Even basic RAG solutions can cause trouble doing exactly what they said they…
0
49
0
@byrondcrowe
Byron Crowe
6 months
Tweet media one
0
996
0
@byrondcrowe
Byron Crowe
9 months
RT @SebastianCaliri: AI medical scribes aren’t giving my portfolio companies much contribution margin lift. We can reduce scribe-to-provi…
0
3
0
@byrondcrowe
Byron Crowe
9 months
@chrissyfarr @healthapiguy @mandl @Farzad_MD @SavageLucia @AaronMiri Is it too cynical to think that it’s going to look basically the same, but with some additional buttons for AI features? Beth Israel is turning Epic on this summer - it looks basically the same as the Epic I used 10 years ago, but cleaner.
1
0
1